RF
DGX icon

Roxbury Financial’s Quest Diagnostics DGX Stock Holding History

Roxbury Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
53
+1
+2% +$196 0.01% 313
2026
Q1 		$10.3K Hold
52
– – 0.01% 302
2025
Q4 		$9.04K Hold
52
– – 0.01% 301
2025
Q3 		$9.89K Hold
52
– – 0.01% 288
2025
Q2 		$9.27K Buy
52
+1
+2% +$174 0.01% 285
2025
Q1 		$8.88K Hold
51
– – 0.01% 280
2024
Q4 		$8.32K Buy
+51
New +$7.93K 0.01% 309

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Roxbury Financial's DGX Position: Q2 2026 in Review

Roxbury Financial increased its Quest Diagnostics (DGX) stake by 1.9% in Q2 2026, buying an estimated $196 and bringing the position to 53 shares worth $11.1K. The position accounts for 0.01% of the portfolio, ranked #313.

Roxbury Financial first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Roxbury Financial held 53 shares of Quest Diagnostics worth $11.1K as of Q2 2026.
  • Roxbury Financial bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
  • Quest Diagnostics made up 0.01% of Roxbury Financial's portfolio in Q2 2026, its #313 holding.
  • Roxbury Financial first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Roxbury Financial's 13F filing for Q2 2026, filed 1 Jul 2026.